동물 의료용 모노클로널 항체 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 동물 유형별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Monoclonal Antibodies In Veterinary Health Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Animal Type, By Application, End-User, By Region, & Competition, 2020-2030F

US $ 4,500 ￦ 6,511,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,957,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,575,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

세계의 동물 의료용 모노클로널 항체 시장 규모는 2024년에 9억 340만 달러에 달하며, 2030년까지 CAGR은 15.50%로 예측됩니다. 동물용 의료용 모노클로널 항체(mAb) 세계 시장은 광범위한 동물 헬스케어 산업에서 빠르게 성장하고 있는 분야입니다. 단클론 항체는 특정 항원을 표적으로 삼을 수 있는 실험실에서 생산된 항체로, 치료 및 진단 용도로 수의학에서 점점 더 많이 사용되고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	9억 340만 달러
시장 규모 : 2030년	21억 4,929만 달러
CAGR: 2025-2030년	15.50%
급성장 부문	피부과
최대 시장	북미

주요 시장 성장 촉진요인

반려동물 사육 증가와 애완동물 인간화

주요 시장 이슈

높은 개발 비용

주요 시장 동향

표적치료 확대

목차

제1장 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 동물 의료용 모노클로널 항체 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 동물 유형별(개, 기타)
  • 용도별(피부과, 통증과, 기타)
  • 최종사용자별(동물병원, 기타)
  • 지역별
  • 기업별(2024년)
• 제품 시장 맵
  • 동물 유형별
  • 용도별
  • 최종사용자별
  • 지역별

제6장 북미의 동물 의료용 모노클로널 항체 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 캐나다
  • 멕시코

제7장 유럽의 동물 의료용 모노클로널 항체 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인

제8장 아시아태평양의 동물 의료용 모노클로널 항체 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 일본
  • 인도
  • 호주
  • 한국

제9장 남미의 동물 의료용 모노클로널 항체 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 동물 의료용 모노클로널 항체 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제11장 시장 역학

• 촉진요인
• 과제

제12장 시장 동향과 발전

• 최근 동향
• 합병과 인수
• 제품 출시

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 힘
• 고객의 힘
• 대체품의 위협

제14장 경쟁 구도

• Zoetis Inc.
• Merck & Co., Inc.
• Elanco LLC
• Boehringer Ingelheim GmbH
• Indian Immunologicals Ltd
• Virbac SA

제15장 전략적 제안

제16장 조사회사 소개·면책사항

KSA

영문 목차

영문목차

Global Monoclonal Antibodies In Veterinary Health Market was valued at USD 903.40 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 15.50% through 2030. The global monoclonal antibodies (mAbs) in veterinary health market represents a rapidly growing segment within the broader animal healthcare industry. Monoclonal antibodies, which are lab-engineered antibodies that can target specific antigens, are increasingly being adopted in veterinary medicine for their therapeutic and diagnostic applications.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 903.40 Million
Market Size 2030	USD 2149.29 Million
CAGR 2025-2030	15.50%
Fastest Growing Segment	Dermatology
Largest Market	North America

Key Market Drivers

Increasing Companion Animal Ownership and Pet Humanization

The increasing trend of companion animal ownership, coupled with the growing humanization of pets, is a major driver of the Global Monoclonal Antibodies (mAbs) in the Veterinary Health Market. Over 50% of the global population is estimated to own a pet, with dogs being the most prevalent, found in approximately 33% of households worldwide. Cats are the second most popular choice, owned by nearly 25% of pet-keeping households. This widespread pet ownership trend reflects a significant and growing market opportunity for pet-related industries, including food, healthcare, accessories, and services, driven by increasing consumer demand and the human-animal bond. As pet owners demand higher-quality healthcare solutions for their animals, the market for advanced veterinary therapeutics, including monoclonal antibody-based treatments, is experiencing significant growth.

Households in the U.S., EU, and China collectively own over 500 million dogs and cats, underscoring a massive and expanding market for pet healthcare solutions. In the U.S., pet ownership grew from 68% of households in 2016 to 70% in 2021, reflecting a sustained upward trend in companion animal adoption and increased consumer spending on veterinary care. Over the past decade, there has been a significant increase in pet adoption rates, particularly in developed economies such as North America, Europe, and parts of Asia-Pacific. Factors such as rising disposable incomes, changing lifestyles, and a growing preference for emotional companionship have contributed to this trend. With pet ownership on the rise, there is a corresponding increase in demand for effective veterinary treatments, including monoclonal antibodies for conditions such as arthritis, dermatological disorders, and cancer.

Key Market Challenges

High Development Costs

Developing monoclonal antibodies is a complex and expensive process. Research and development costs can be prohibitively high, which poses a significant challenge for smaller biotech companies and startups looking to enter the market. These high costs can limit the diversity of players and the range of mAb products available..

Key Market Trends

Expansion of Targeted Therapies

One of the most significant upcoming trends is the expansion of targeted therapies using monoclonal antibodies. As our understanding of animal diseases and their molecular mechanisms deepens, researchers are developing mAbs that can target specific disease pathways with precision. This trend promises to provide veterinarians with a broader range of effective treatment options for a variety of conditions.

Key Market Players

• Zoetis Inc.
• Merck & Co., Inc.
• Elanco LLC
• Boehringer Ingelheim GmbH
• Indian Immunologicals Ltd
• Virbac SA

Report Scope:

In this report, the Global Monoclonal Antibodies In Veterinary Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Monoclonal Antibodies In Veterinary Health Market, By Animal Type:

• Dogs
• Others

Monoclonal Antibodies In Veterinary Health Market, By Application:

• Dermatology
• Pain
• Others

Monoclonal Antibodies In Veterinary Health Market, By End-User:

• Veterinary Hospitals
• Others

Monoclonal Antibodies In Veterinary Health Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Monoclonal Antibodies In Veterinary Health Market.

Available Customizations:

Global Monoclonal Antibodies In Veterinary Health market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Monoclonal Antibodies In Veterinary Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Dogs, Others)
  • 5.2.2. By Application (Dermatology, Pain, Others)
  • 5.2.3. By End-User (Veterinary Hospitals, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Animal Type
  • 5.3.2. By Application
  • 5.3.3. By End-User
  • 5.3.4. By Region

6. North America Monoclonal Antibodies In Veterinary Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type (Dogs, Others)
  • 6.2.2. By Application (Dermatology, Pain, Others)
  • 6.2.3. By End-User (Veterinary Hospitals, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Monoclonal Antibodies In Veterinary Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Monoclonal Antibodies In Veterinary Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Monoclonal Antibodies In Veterinary Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User

7. Europe Monoclonal Antibodies In Veterinary Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type (Dogs, Others)
  • 7.2.2. By Application (Dermatology, Pain, Others)
  • 7.2.3. By End-User (Veterinary Hospitals, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Monoclonal Antibodies In Veterinary Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. United Kingdom Monoclonal Antibodies In Veterinary Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. France Monoclonal Antibodies In Veterinary Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Monoclonal Antibodies In Veterinary Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Monoclonal Antibodies In Veterinary Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. Asia-Pacific Monoclonal Antibodies In Veterinary Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type (Dogs, Others)
  • 8.2.2. By Application (Dermatology, Pain, Others)
  • 8.2.3. By End-User (Veterinary Hospitals, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Monoclonal Antibodies In Veterinary Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. Japan Monoclonal Antibodies In Veterinary Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. India Monoclonal Antibodies In Veterinary Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User
  • 8.3.4. Australia Monoclonal Antibodies In Veterinary Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Animal Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-User
  • 8.3.5. South Korea Monoclonal Antibodies In Veterinary Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Animal Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-User

9. South America Monoclonal Antibodies In Veterinary Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type (Dogs, Others)
  • 9.2.2. By Application (Dermatology, Pain, Others)
  • 9.2.3. By End-User (Veterinary Hospitals, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Monoclonal Antibodies In Veterinary Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. Argentina Monoclonal Antibodies In Veterinary Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. Colombia Monoclonal Antibodies In Veterinary Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. Middle East and Africa Monoclonal Antibodies In Veterinary Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type (Dogs, Others)
  • 10.2.2. By Application (Dermatology, Pain, Others)
  • 10.2.3. By End-User (Veterinary Hospitals, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Monoclonal Antibodies In Veterinary Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Saudi Arabia Monoclonal Antibodies In Veterinary Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. UAE Monoclonal Antibodies In Veterinary Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User
  • 10.3.4. Kuwait Monoclonal Antibodies In Veterinary Health Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Animal Type
      • 10.3.4.2.2. By Application
      • 10.3.4.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Zoetis Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offering
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (as reported)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Merck & Co., Inc.
• 14.3. Elanco LLC
• 14.4. Boehringer Ingelheim GmbH
• 14.5. Indian Immunologicals Ltd
• 14.6. Virbac SA

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료